Chasing Life
Is Ozempic Really A Miracle Drug?
Jan 30, 2024
Dr. Jorge Moreno, Yale School of Medicine assistant professor, discusses new drugs for weight loss like Ozempic, exploring their benefits, risks, and unknowns. He explains how medications like Ozempic trick the brain into feeling full, highlights the similarities and differences between available weight loss medications, and addresses eligibility criteria and stigma associated with taking these drugs. The podcast also touches on the future of diabetes medications, including potential long-term effects, upcoming triple agonist drug, and affordability issues.
30:13
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Obesity medications like Ozempic and Wegovy, which mimic a hormone called GLP1, have been shown to help patients lose an average of 15% of their weight over 68 weeks.
- It is crucial to follow the indications for these medications, as they have specific criteria for use, and close follow-up and ongoing management are necessary to monitor for side effects and ensure optimal outcomes.
Deep dives
Overview of Obesity Medications
In this podcast episode, Dr. Jorge Moreno, an obesity medicine expert, discusses the rise in popularity of obesity medications. He emphasizes that obesity is a serious disease and deserves aggressive treatment. He explains that these medications work by mimicking a hormone called GLP1, which activates appetite centers in the brain and reduces food cravings. Dr. Moreno highlights the effectiveness of semaglutide-based medications, such as Ozempic and Weggovy, which have been shown to help patients lose an average of 15% of their weight over a period of 68 weeks. He also mentions the potential long-term use of these medications, comparing obesity management to the management of chronic conditions like diabetes.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
